Speaker Profile

DPhil, CTO & President of Platform, Relation Therapeutics

Biography
Originally a specialist in systems biology, Lindsay joined GlaxoSmithKline in 2014 from the faculty of King’s College London. He started GSK’s first Data Science group, before becoming VP of AI/ML Engineering. He joined AstraZeneca as VP of AI in 2020, delivering complex models into production and publishing in some of machine learning’s most respected forums. He also led a small data science team working on the critical path of the Oxford-AstraZeneca COVID vaccine. His background spans machine learning, data science and bioinformatics but also human physiology, metabolic biochemistry and metabolomics. He has previously held academic appointments in both Australia and the UK. He holds a DPhil in Physiology from Oxford, has published more than 40 articles in peer-reviewed journals and is an accomplished public speaker. Before becoming a scientist, he was a successful musician and record producer and counts a number of UK Top Ten singles and multiple platinum albums to his credit.


 Session Abstract – PMWC 2022 Silicon Valley


  • Hope or Hype? The Role of ML in Drug Discovery and Development (PANEL)
    Session Chair: Ansuman Satpathy, Stanford University
    - Marcel Hop, Genentech
    - Noam Solomon, ImmunAI
    - Stacie Calad-Thomson, BioSymetrics
    - Andrea deSouza, Eli Lilly and Company
  • Advancing Research and Drug Discovery with UK Biobank
    Session Chair: Asha Collins, DNAnexus
    - Mahesh Pancholi, UK Biobank
  • Machine Learning for Novel Target Discovery: Unique Techniques Meet Unique Data
    Session Chair: Alex Morgan, Khosla Ventures
    - Lindsay Edwards, Relation Therapeutics
    - Kristen Fortney, BioAge
    - Quin Wills, Ochre Bio
    - Joseph Rodgers, Fountain Therapeutics
    - Calum MacRae, Atman Health
  • AI in Small Molecule Design and Screening (PANEL)
    Session Chair: Alex Zhavoronkov, Insilico Medicine
    - Jim Edwards, Janssen
    - Tommaso Mansi, Johnson & Johnson
    - Martin Emanuel Bittner, Arctoris
  • AI/ML in Clinical Trial Design, Patient Selection and Prediction of Outcomes (PANEL)
    Session Chair: Peter Lipsky, Ampel Bio
    - Nasim Eftekhari, City of Hope
    - Mika Newton, xCures, Inc.
    - Mark Smith, MedStar Health
    - William Oh, Sema4
  • Treating Genetics as Data: Computable, Structured Results for Precision Medicine
    - Peter DeVault, Epic
  • PMWC 2022 Showcase
    - Kevin Cho, Envisagenics, Inc.
    - Poojitha Ojamies, Novartis
    - Steve Harrison, Engine Biosciences